Last reviewed · How we verify
Low-Molecular-Weight Heparins Calcium Injection
Low-Molecular-Weight Heparins Calcium Injection is a Small molecule drug developed by Capital Institute of Pediatrics, China. It is currently FDA-approved.
At a glance
| Generic name | Low-Molecular-Weight Heparins Calcium Injection |
|---|---|
| Sponsor | Capital Institute of Pediatrics, China |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） (PHASE4)
- A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery
- A Study of Enhancing Drug Prophylaxis of Venous Thromboembolism in Chinese Colorectal Cancer Surgery
- Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer (PHASE4)
- Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype (PHASE1, PHASE2)
- Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection (PHASE4)
- Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy (PHASE4)
- Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Low-Molecular-Weight Heparins Calcium Injection CI brief — competitive landscape report
- Low-Molecular-Weight Heparins Calcium Injection updates RSS · CI watch RSS
- Capital Institute of Pediatrics, China portfolio CI
Frequently asked questions about Low-Molecular-Weight Heparins Calcium Injection
What is Low-Molecular-Weight Heparins Calcium Injection?
Low-Molecular-Weight Heparins Calcium Injection is a Small molecule drug developed by Capital Institute of Pediatrics, China.
Who makes Low-Molecular-Weight Heparins Calcium Injection?
Low-Molecular-Weight Heparins Calcium Injection is developed and marketed by Capital Institute of Pediatrics, China (see full Capital Institute of Pediatrics, China pipeline at /company/capital-institute-of-pediatrics-china).
What development phase is Low-Molecular-Weight Heparins Calcium Injection in?
Low-Molecular-Weight Heparins Calcium Injection is FDA-approved (marketed).